The rise of Sildenafil initially fueled a surge for major pharmaceutical companies, but recent changes present a complicated scenario for those considering a stake. Off-patent alternatives are eating into profits, and https://cecilypctp033340.bloggazza.com/39902882/sildenafil-and-the-pharmaceutical-industry-a-risky-bet